StockDrifts LogoStockDrifts

Intron Bio 048530

Company
인트론바이오Intron Bio
Insiders
2
Buys
7
Total Value
₩701M ($487K)
Avg Return
+13.97%
Last Filing
2026-06-08

Intron Bio (048530) has 7 disclosed insider purchases and 0 disclosed disposals on record, filed by 2 distinct insiders. Together those filings cover ₩701M ($487K) in reported transaction value. The earliest filing StockDrifts holds for Intron Bio is dated 2025-01-02; the most recent is 2026-06-08. All of it is parsed from DART D001/D002 insider disclosures, the official disclosure system operated by the Financial Supervisory Service (Korea). Across these filings the average return since disclosure is +13.97%, measured from each filing date to the latest available close.

Price & insider activity (12 months)

Recent insider trades

DateTypeSourceInsiderPositionSharesPrice at filingReturnValue
2026-06-08BUYMarket Buy
윤경원
Kyeong-won Yoon
CEO/Vice President38.6K---
2026-03-19SELL임원퇴임
전수연
Sooyeon Jeon
Sooyeon Jeon-20.8K₩4,610+9.1%₩96M ($67K)
2026-02-20SELL임원퇴임
설재구
Seol Jae-gu
Seol Jae-gu-31.1K₩3,640-15.1%₩113M ($78K)
2026-01-29SELL임원퇴임
김수진
Sujin Kim
Sujin Kim-7.0K₩4,020-4.2%₩28M ($20K)
2026-01-20BUYMarket Buy
윤경원
Kyeong-won Yoon
CEO/Vice President49.8K₩3,055+37.1%₩152M ($106K)
2026-01-19SELL임원퇴임
강상현
Sanghyun Kang
vice president-99.0K₩2,915-43.7%₩288M ($200K)
2026-01-05BUY신규선임
손지수
Jisoo Son
moving535₩3,265+28.3%₩2M ($1K)
2025-12-17SELL장외매도
윤성준
Seongjun Yoon
CEO-1.0M₩3,480-20.4%₩3.5B ($2.4M)
2025-11-21BUYMarket Buy
윤경원
Kyeong-won Yoon
CEO/Vice President30.0K₩3,730+12.3%₩112M ($78K)
2025-11-20BUYMarket Buy
윤경원
Kyeong-won Yoon
CEO/Vice President35.0K₩3,790+10.6%₩133M ($92K)
2025-11-19BUYMarket Buy
윤경원
Kyeong-won Yoon
CEO/Vice President32.0K₩3,655+14.6%₩117M ($81K)
2025-11-18BUYMarket Buy
윤경원
Kyeong-won Yoon
CEO/Vice President33.0K₩3,665+14.3%₩121M ($84K)
2025-02-20BUYMarket Buy
강상현
Sanghyun Kang
vice president15.0K₩4,420-5.2%₩66M ($46K)
2025-01-02BUY신규선임
김성우
Seongwoo Kim
moving10.8K₩5,600-25.2%₩61M ($42K)

Frequently asked questions

Who has been buying Intron Bio stock?
2 distinct insiders have filed 7 disclosed insider purchases in Intron Bio (048530), most recently on 2026-06-08. Each filer, their role, the number of shares and the price at filing are listed in the table on this page.
How many insider filings does Intron Bio have?
Intron Bio has 7 buy-side and 0 sell-side disclosures on record, covering ₩701M ($487K) in total reported value, spanning 2025-01-02 to 2026-06-08.
Where does StockDrifts get Intron Bio insider data?
From DART D001/D002 insider disclosures — the official filing system run by the Financial Supervisory Service (Korea). StockDrifts parses each disclosure and matches it to daily price history; the original filings remain available directly from DART.
Do insider buys in Korean stocks predict returns?
Not uniformly. StockDrifts analysed 170,720 share-count changes across 56,930 Korean DART filings using cross-sectional alpha at fixed forward horizons, and found returns concentrated in particular signal tiers rather than in insider buying generally.

Source filings

Every trade listed above is disclosed in DART D001/D002 insider disclosures, filed with the Financial Supervisory Service (Korea). View the original DART filings for Intron Bio. For how StockDrifts scores these disclosures, see the Korea insider signal tier research, or browse every Korean stock we track.